Prostate Cancer - Results from #28460

Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy - Abstract March 14, 2011

Male pattern baldness and the risk of prostate cancer - Abstract March 14, 2011

Examining risk perception among men with a family history of prostate cancer - Abstract March 11, 2011

Stage-by-stage effects of surgical margin status on biochemical failure after radical prostatectomy in patients with clinically localized prostate cancer - Abstract March 11, 2011

Novel agents and new therapeutics in castration-resistant prostate cancer - Abstract March 11, 2011

Surgical anatomy of the prostate in the ERA of radical robotic prostatectomy - Abstract March 11, 2011

A critical analysis of the long-term impact of brachytherapy for prostate cancer: A review of the recent literature - Abstract March 11, 2011

Contemporary imaging analyses of pelvic lymph nodes in the prostate cancer patient - Abstract March 11, 2011

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer - Abstract March 11, 2011

Combined intensity-modulated radiation therapy vs. three-dimensional highly conformal radiotherapy after (125)I prostate permanent seed brachytherapy: A comparative treatment planning study - Abstract March 11, 2011

Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival - Abstract March 11, 2011

Editor's Commentary - The influence of family history on prostate cancer risk: Implications for clinical management March 11, 2011

Impact of genotyping on outcome of prostatic biopsies: A multicentre prospective study - Abstract March 10, 2011

Distribution of the lymphatic vessels in the prostatic fascia - Abstract March 10, 2011

High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: Hemi-irradiation of prostate cancer - Abstract March 10, 2011

Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia? - Abstract March 10, 2011

Docetaxel-mediated apoptosis in myeloid progenitor TF-1 cells is mitigated by zinc: Potential implication for prostate cancer therapy - Abstract March 10, 2011

Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer - Abstract March 10, 2011

High-dose-rate monotherapy: Safe and effective brachytherapy for patients with localized prostate cancer - Abstract March 10, 2011

Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy - Abstract March 10, 2011

Page 1424 of 1436